Melanoma-associated paraneoplastic retinopathy: case report and review of the literature, Br J Dermatol, vol.137, pp.457-460, 1997. ,
Paraneoplastic night blindness with malignant melanoma, Am J Ophthalmol, vol.106, pp.307-311, 1988. ,
Melanoma-associated retinopathy: a paraneoplastic autoimmune complication, Arch Ophthalmol, vol.127, pp.1572-1580, 2009. ,
Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management, Surv Ophthalmol, vol.58, pp.430-458, 2013. ,
Paraneoplastic retinopathies and optic neuropathies, Surv Ophthalmol, vol.48, pp.12-38, 2003. ,
Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells, N Engl J Med, vol.321, pp.1589-1594, 1989. ,
Cancer-associated retinopathy, Arch Ophthalmol, vol.105, pp.372-375, 1987. ,
Autoimmune retinopathy: A Review, Int J Retina Vitreous, vol.4, p.29340169, 2018. ,
On' response defect in paraneoplastic night blindness with cutaneous malignant melanoma, Invest Ophthalmol Vis Sci, vol.33, pp.477-483, 1992. ,
Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction, PLoS One, vol.6, 2011. ,
Cancer-associated retinopathy (CAR) with electronegative ERG: a case report, Doc Ophthalmol, vol.116, p.17721792, 2008. ,
Cancer-associated retinopathy presenting as retinal vasculitis with a negative ERG suggestive of on-bipolar cell pathway dysfunction, Doc Ophthalmol, vol.123, p.21674222, 2011. ,
Cutaneous melanoma-associated retinopathy with retinal periphlebitis, Arch Ophthalmol, vol.113, pp.854-855, 1995. ,
, , 2006.
, Nippon Ganka Gakkai Zasshi, vol.110, pp.211-217
Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases, J Neuroophthalmol, vol.21, pp.173-187, 2001. ,
Chorioretinal Lesions in a Case of Melanoma-Associated Retinopathy Treated With Pembrolizumab, JAMA Ophthalmol, vol.134, pp.1184-1188, 2016. ,
Analysis of the human electroretinogram, Ophthalmologica, vol.123, pp.396-413, 1952. ,
Congenital stationary night blindness with negative electroretinogram. A new classification, Arch Ophthalmol, vol.104, pp.1013-1020, 1986. ,
Congenital stationary night blindness: an analysis and update of genotype-phenotype correlations and pathogenic mechanisms, Prog Retin Eye Res, vol.45, pp.58-110, 2015. ,
ISCEV Standard for fullfield clinical electroretinography (2015 update), Doc Ophthalmol, vol.130, pp.1-12, 2015. ,
TRPM1 is mutated in patients with autosomal-recessive complete congenital stationary night blindness, Am J Hum Genet, vol.85, pp.720-729, 2009. ,
Autoantibodies in melanoma-associated retinopathy target TRPM1 cation channels of retinal ON bipolar cells, J Neurosci, vol.31, pp.3962-3967, 2011. ,
Autoantibody against transient receptor potential M1 cation channels of retinal ON bipolar cells in paraneoplastic vitelliform retinopathy, BMC Ophthalmol, vol.12, p.23148706, 2012. ,
Serum TRPM1 autoantibodies from melanoma associated retinopathy patients enter retinal on-bipolar cells and attenuate the electroretinogram in mice, PLoS One, vol.8, p.69506, 2013. ,
Degeneration of retinal on bipolar cells induced by serum including autoantibody against TRPM1 in mouse model of paraneoplastic retinopathy, PLoS One, vol.8, p.81507, 2013. ,
Diagnosis of occult melanoma using transient receptor potential melastatin 1 (TRPM1) autoantibody testing: a novel approach, Ophthalmology, vol.120, pp.2560-2564, 2013. ,
Autoantibodies to transient receptor potential cation channel, subfamily M, member 1 in a Japanese patient with melanoma-associated retinopathy, Jpn J Ophthalmol, vol.58, p.24468869, 2014. ,
Choroidal atrophy in a patient with paraneoplastic retinopathy and anti-TRPM1 antibody, Clin Ophthalmol, vol.8, pp.369-373, 2014. ,
Case of paraneoplastic retinopathy with retinal ON-bipolar cell dysfunction and subsequent resolution of ERGs, Doc Ophthalmol, vol.130, p.25391361, 2015. ,
Autoantibodies in Melanoma-Associated Retinopathy Recognize an Epitope Conserved Between TRPM1 and TRPM3, Invest Ophthalmol Vis Sci, vol.58, pp.2732-2738, 2017. ,
Unilateral cancer-associated retinopathy: diagnosis, serology and treatment, Doc Ophthalmol, vol.135, p.28815346, 2017. ,
Clinical Course of Paraneoplastic Retinopathy with Anti-Trpm1 Autoantibody in Japanese Cohort, 2018. ,
, TRPM1 Autoantibodies in Melanoma Patients Without Self-Reported Visual Symptoms, vol.60, pp.2330-2335, 2019.
Neoplasia and intraocular inflammation: From masquerade syndromes to immunotherapy-induced uveitis, Prog Retin Eye Res, vol.72, p.100761, 2019. ,
Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo, Invest Ophthalmol Vis Sci, vol.41, pp.262-266, 2000. ,
Anti-TRPM1 antibodies in patients with retinal degeneration, Clin Exp Ophthalmol, vol.46, pp.1087-1089, 2018. ,
Recoverin, a photoreceptorspecific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy, Proc Natl Acad Sci U S A, vol.92, pp.9176-9180, 1995. ,
The regulation of miRNA-211 expression and its role in melanoma cell invasiveness, PLoS One, vol.5, p.13779, 2010. ,
Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma, Mol Cell, vol.40, pp.841-849, 2010. ,
Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor, Pigment Cell Melanoma Res, vol.24, p.21435193, 2011. ,
Human melastatin 1 (TRPM1) is regulated by MITF and produces multiple polypeptide isoforms in melanocytes and melanoma, Melanoma Res, vol.14, pp.509-516, 2004. ,
Expression and Up-regulation of alternatively spliced transcripts of melastatin, a melanoma metastasis-related gene, in human melanoma cells, Biochem Biophys Res Commun, vol.279, pp.53-61, 2000. ,
An unusual retinal phenotype associated with a novel mutation in RHO, Arch Ophthalmol, vol.128, pp.1036-1045, 2010. ,
TRPM1 forms complexes with nyctalopin in vivo and accumulates in postsynaptic compartment of ON-bipolar neurons in mGluR6-dependent manner, J Neurosci, vol.31, pp.11521-11526, 2011. ,
Survival of cutaneous melanoma based on sex, age, and stage in the United States, Cancer Med, vol.6, pp.2203-2212, 1992. ,
Sex differences in rising trends of cutaneous malignant melanoma in Norway, Melanoma Res, vol.23, pp.70-78, 2013. ,
Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy, BMC Ophthalmol, vol.4, 2004. ,
Autoimmune retinopathy and antiretinal antibodies: a review, Retina, vol.34, pp.827-845, 2014. ,
Autoimmunity against carbonic anhydrase II affects retinal cell functions in autoimmune retinopathy, J Autoimmun, vol.32, pp.133-139, 2009. ,